Global Pharmacogenomics Technology (Theranostics & CDx) Market Insights and Forecast to 2031

Report ID: 1227778 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Instrument
        1.2.3 Reagents and Consumables
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Tumor
        1.3.3 Diabetes
        1.3.4 Mental Diseases
        1.3.5 Cardiovascular Diseases
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Pharmacogenomics Technology (Theranostics & CDx) Market Perspective (2017-2028)
    2.2 Pharmacogenomics Technology (Theranostics & CDx) Growth Trends by Region
        2.2.1 Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Pharmacogenomics Technology (Theranostics & CDx) Historic Market Size by Region (2017-2022)
        2.2.3 Pharmacogenomics Technology (Theranostics & CDx) Forecasted Market Size by Region (2023-2028)
    2.3 Pharmacogenomics Technology (Theranostics & CDx) Market Dynamics
        2.3.1 Pharmacogenomics Technology (Theranostics & CDx) Industry Trends
        2.3.2 Pharmacogenomics Technology (Theranostics & CDx) Market Drivers
        2.3.3 Pharmacogenomics Technology (Theranostics & CDx) Market Challenges
        2.3.4 Pharmacogenomics Technology (Theranostics & CDx) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Pharmacogenomics Technology (Theranostics & CDx) Players by Revenue
        3.1.1 Global Top Pharmacogenomics Technology (Theranostics & CDx) Players by Revenue (2017-2022)
        3.1.2 Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share by Players (2017-2022)
    3.2 Global Pharmacogenomics Technology (Theranostics & CDx) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Pharmacogenomics Technology (Theranostics & CDx) Revenue
    3.4 Global Pharmacogenomics Technology (Theranostics & CDx) Market Concentration Ratio
        3.4.1 Global Pharmacogenomics Technology (Theranostics & CDx) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pharmacogenomics Technology (Theranostics & CDx) Revenue in 2021
    3.5 Pharmacogenomics Technology (Theranostics & CDx) Key Players Head office and Area Served
    3.6 Key Players Pharmacogenomics Technology (Theranostics & CDx) Product Solution and Service
    3.7 Date of Enter into Pharmacogenomics Technology (Theranostics & CDx) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacogenomics Technology (Theranostics & CDx) Breakdown Data by Type
    4.1 Global Pharmacogenomics Technology (Theranostics & CDx) Historic Market Size by Type (2017-2022)
    4.2 Global Pharmacogenomics Technology (Theranostics & CDx) Forecasted Market Size by Type (2023-2028)
5 Pharmacogenomics Technology (Theranostics & CDx) Breakdown Data by Application
    5.1 Global Pharmacogenomics Technology (Theranostics & CDx) Historic Market Size by Application (2017-2022)
    5.2 Global Pharmacogenomics Technology (Theranostics & CDx) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Pharmacogenomics Technology (Theranostics & CDx) Market Size (2017-2028)
    6.2 North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type
        6.2.1 North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022)
        6.2.2 North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2023-2028)
        6.2.3 North America Pharmacogenomics Technology (Theranostics & CDx) Market Share by Type (2017-2028)
    6.3 North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application
        6.3.1 North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022)
        6.3.2 North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2023-2028)
        6.3.3 North America Pharmacogenomics Technology (Theranostics & CDx) Market Share by Application (2017-2028)
    6.4 North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country
        6.4.1 North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2017-2022)
        6.4.2 North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size (2017-2028)
    7.2 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type
        7.2.1 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022)
        7.2.2 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2023-2028)
        7.2.3 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Share by Type (2017-2028)
    7.3 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application
        7.3.1 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022)
        7.3.2 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2023-2028)
        7.3.3 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Share by Application (2017-2028)
    7.4 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country
        7.4.1 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2017-2022)
        7.4.2 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size (2017-2028)
    8.2 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type
        8.2.1 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Share by Type (2017-2028)
    8.3 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application
        8.3.1 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Share by Application (2017-2028)
    8.4 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region
        8.4.1 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size (2017-2028)
    9.2 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type
        9.2.1 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022)
        9.2.2 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2023-2028)
        9.2.3 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Share by Type (2017-2028)
    9.3 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application
        9.3.1 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022)
        9.3.2 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2023-2028)
        9.3.3 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Share by Application (2017-2028)
    9.4 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country
        9.4.1 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2017-2022)
        9.4.2 Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size (2017-2028)
    10.2 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type
        10.2.1 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Share by Type (2017-2028)
    10.3 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application
        10.3.1 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Share by Application (2017-2028)
    10.4 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country
        10.4.1 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Illumina
        11.1.1 Illumina Company Details
        11.1.2 Illumina Business Overview
        11.1.3 Illumina Pharmacogenomics Technology (Theranostics & CDx) Introduction
        11.1.4 Illumina Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
        11.1.5 Illumina Recent Developments
    11.2 Roche
        11.2.1 Roche Company Details
        11.2.2 Roche Business Overview
        11.2.3 Roche Pharmacogenomics Technology (Theranostics & CDx) Introduction
        11.2.4 Roche Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
        11.2.5 Roche Recent Developments
    11.3 Agilent
        11.3.1 Agilent Company Details
        11.3.2 Agilent Business Overview
        11.3.3 Agilent Pharmacogenomics Technology (Theranostics & CDx) Introduction
        11.3.4 Agilent Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
        11.3.5 Agilent Recent Developments
    11.4 Abbott
        11.4.1 Abbott Company Details
        11.4.2 Abbott Business Overview
        11.4.3 Abbott Pharmacogenomics Technology (Theranostics & CDx) Introduction
        11.4.4 Abbott Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
        11.4.5 Abbott Recent Developments
    11.5 Thermofisher
        11.5.1 Thermofisher Company Details
        11.5.2 Thermofisher Business Overview
        11.5.3 Thermofisher Pharmacogenomics Technology (Theranostics & CDx) Introduction
        11.5.4 Thermofisher Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
        11.5.5 Thermofisher Recent Developments
    11.6 Qiagen
        11.6.1 Qiagen Company Details
        11.6.2 Qiagen Business Overview
        11.6.3 Qiagen Pharmacogenomics Technology (Theranostics & CDx) Introduction
        11.6.4 Qiagen Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
        11.6.5 Qiagen Recent Developments
    11.7 Guardant Health
        11.7.1 Guardant Health Company Details
        11.7.2 Guardant Health Business Overview
        11.7.3 Guardant Health Pharmacogenomics Technology (Theranostics & CDx) Introduction
        11.7.4 Guardant Health Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
        11.7.5 Guardant Health Recent Developments
    11.8 MGI Tech Co., Ltd.
        11.8.1 MGI Tech Co., Ltd. Company Details
        11.8.2 MGI Tech Co., Ltd. Business Overview
        11.8.3 MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics & CDx) Introduction
        11.8.4 MGI Tech Co., Ltd. Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
        11.8.5 MGI Tech Co., Ltd. Recent Developments
    11.9 Amoydx Biology
        11.9.1 Amoydx Biology Company Details
        11.9.2 Amoydx Biology Business Overview
        11.9.3 Amoydx Biology Pharmacogenomics Technology (Theranostics & CDx) Introduction
        11.9.4 Amoydx Biology Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
        11.9.5 Amoydx Biology Recent Developments
    11.10 Genomics
        11.10.1 Genomics Company Details
        11.10.2 Genomics Business Overview
        11.10.3 Genomics Pharmacogenomics Technology (Theranostics & CDx) Introduction
        11.10.4 Genomics Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
        11.10.5 Genomics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Instrument
    Table 3. Key Players of Reagents and Consumables
    Table 4. Key Players of Others
    Table 5. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Pharmacogenomics Technology (Theranostics & CDx) Market Share by Region (2017-2022)
    Table 9. Global Pharmacogenomics Technology (Theranostics & CDx) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Pharmacogenomics Technology (Theranostics & CDx) Market Share by Region (2023-2028)
    Table 11. Pharmacogenomics Technology (Theranostics & CDx) Market Trends
    Table 12. Pharmacogenomics Technology (Theranostics & CDx) Market Drivers
    Table 13. Pharmacogenomics Technology (Theranostics & CDx) Market Challenges
    Table 14. Pharmacogenomics Technology (Theranostics & CDx) Market Restraints
    Table 15. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Share by Players (2017-2022)
    Table 17. Global Top Pharmacogenomics Technology (Theranostics & CDx) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Technology (Theranostics & CDx) as of 2021)
    Table 18. Ranking of Global Top Pharmacogenomics Technology (Theranostics & CDx) Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Pharmacogenomics Technology (Theranostics & CDx) Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Pharmacogenomics Technology (Theranostics & CDx) Product Solution and Service
    Table 22. Date of Enter into Pharmacogenomics Technology (Theranostics & CDx) Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share by Type (2017-2022)
    Table 26. Global Pharmacogenomics Technology (Theranostics & CDx) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share by Type (2023-2028)
    Table 28. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Share by Application (2017-2022)
    Table 30. Global Pharmacogenomics Technology (Theranostics & CDx) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Share by Application (2023-2028)
    Table 32. North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Illumina Company Details
    Table 63. Illumina Business Overview
    Table 64. Illumina Pharmacogenomics Technology (Theranostics & CDx) Product
    Table 65. Illumina Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022) & (US$ Million)
    Table 66. Illumina Recent Developments
    Table 67. Roche Company Details
    Table 68. Roche Business Overview
    Table 69. Roche Pharmacogenomics Technology (Theranostics & CDx) Product
    Table 70. Roche Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022) & (US$ Million)
    Table 71. Roche Recent Developments
    Table 72. Agilent Company Details
    Table 73. Agilent Business Overview
    Table 74. Agilent Pharmacogenomics Technology (Theranostics & CDx) Product
    Table 75. Agilent Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022) & (US$ Million)
    Table 76. Agilent Recent Developments
    Table 77. Abbott Company Details
    Table 78. Abbott Business Overview
    Table 79. Abbott Pharmacogenomics Technology (Theranostics & CDx) Product
    Table 80. Abbott Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022) & (US$ Million)
    Table 81. Abbott Recent Developments
    Table 82. Thermofisher Company Details
    Table 83. Thermofisher Business Overview
    Table 84. Thermofisher Pharmacogenomics Technology (Theranostics & CDx) Product
    Table 85. Thermofisher Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022) & (US$ Million)
    Table 86. Thermofisher Recent Developments
    Table 87. Qiagen Company Details
    Table 88. Qiagen Business Overview
    Table 89. Qiagen Pharmacogenomics Technology (Theranostics & CDx) Product
    Table 90. Qiagen Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022) & (US$ Million)
    Table 91. Qiagen Recent Developments
    Table 92. Guardant Health Company Details
    Table 93. Guardant Health Business Overview
    Table 94. Guardant Health Pharmacogenomics Technology (Theranostics & CDx) Product
    Table 95. Guardant Health Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022) & (US$ Million)
    Table 96. Guardant Health Recent Developments
    Table 97. MGI Tech Co., Ltd. Company Details
    Table 98. MGI Tech Co., Ltd. Business Overview
    Table 99. MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics & CDx) Product
    Table 100. MGI Tech Co., Ltd. Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022) & (US$ Million)
    Table 101. MGI Tech Co., Ltd. Recent Developments
    Table 102. Amoydx Biology Company Details
    Table 103. Amoydx Biology Business Overview
    Table 104. Amoydx Biology Pharmacogenomics Technology (Theranostics & CDx) Product
    Table 105. Amoydx Biology Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022) & (US$ Million)
    Table 106. Amoydx Biology Recent Developments
    Table 107. Genomics Company Details
    Table 108. Genomics Business Overview
    Table 109. Genomics Pharmacogenomics Technology (Theranostics & CDx) Product
    Table 110. Genomics Revenue in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022) & (US$ Million)
    Table 111. Genomics Recent Developments
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pharmacogenomics Technology (Theranostics & CDx) Market Share by Type: 2021 VS 2028
    Figure 2. Instrument Features
    Figure 3. Reagents and Consumables Features
    Figure 4. Others Features
    Figure 5. Global Pharmacogenomics Technology (Theranostics & CDx) Market Share by Application: 2021 VS 2028
    Figure 6. Tumor Case Studies
    Figure 7. Diabetes Case Studies
    Figure 8. Mental Diseases Case Studies
    Figure 9. Cardiovascular Diseases Case Studies
    Figure 10. Others Case Studies
    Figure 11. Pharmacogenomics Technology (Theranostics & CDx) Report Years Considered
    Figure 12. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Pharmacogenomics Technology (Theranostics & CDx) Market Share by Region: 2021 VS 2028
    Figure 15. Global Pharmacogenomics Technology (Theranostics & CDx) Market Share by Players in 2021
    Figure 16. Global Top Pharmacogenomics Technology (Theranostics & CDx) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Technology (Theranostics & CDx) as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Pharmacogenomics Technology (Theranostics & CDx) Revenue in 2021
    Figure 18. North America Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Type (2017-2028)
    Figure 20. North America Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application (2017-2028)
    Figure 21. North America Pharmacogenomics Technology (Theranostics & CDx) Market Size Share by Country (2017-2028)
    Figure 22. United States Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size Share by Country (2017-2028)
    Figure 28. Germany Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Pharmacogenomics Technology (Theranostics & CDx) Market Size Share by Region (2017-2028)
    Figure 38. China Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Pharmacogenomics Technology (Theranostics & CDx) Market Size Share by Country (2017-2028)
    Figure 48. Mexico Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size Share by Country (2017-2028)
    Figure 54. Turkey Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Pharmacogenomics Technology (Theranostics & CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Illumina Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
    Figure 58. Roche Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
    Figure 59. Agilent Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
    Figure 60. Abbott Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
    Figure 61. Thermofisher Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
    Figure 62. Qiagen Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
    Figure 63. Guardant Health Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
    Figure 64. MGI Tech Co., Ltd. Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
    Figure 65. Amoydx Biology Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
    Figure 66. Genomics Revenue Growth Rate in Pharmacogenomics Technology (Theranostics & CDx) Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Illumina
Roche
Agilent
Abbott
Thermofisher
Qiagen
Guardant Health
MGI Tech Co., Ltd.
Amoydx Biology
Genomics
Frequently Asked Questions
Pharmacogenomics Technology (Theranostics & CDx) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pharmacogenomics Technology (Theranostics & CDx) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pharmacogenomics Technology (Theranostics & CDx) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Gaming Monitor

Gaming Monitor market is segmented by Refresh Rate and by Sales Channel. Players, stakeholders, a ... Read More

Barcode Scanner

Barcode Scanner market is segmented by Type and by End User. Players, stakeholders, and other par ... Read More